We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$558M
AUM Growth
+$80.9M
(+17%)
Cap. Flow
+$74.9M
Cap. Flow
% of AUM
13.41%
Top 10 Holdings %
Top 10 Hldgs %
4.09%
Holding
1,998
New
778
Increased
301
Reduced
272
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$3.2M |
| 2 |
Boeing
BA
|
+$2.64M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.42M |
| 4 |
Amgen
AMGN
|
+$2.03M |
| 5 |
Elevance Health
ELV
|
+$1.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.64M |
| 2 |
Lockheed Martin
LMT
|
+$2.31M |
| 3 |
Cigna
CI
|
+$2.21M |
| 4 |
Wells Fargo
WFC
|
+$2.18M |
| 5 |
Paychex
PAYX
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Healthcare | 15.64% |
| 3 | Consumer Discretionary | 14.34% |
| 4 | Industrials | 14.21% |
| 5 | Financials | 12.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LUXE
1251
LuxExperience B.V.
LUXE
$1.16B
| $45.6K | 0.01% |
+11,393
| New | +$54.3K |
|
|
KNDI
1252
Kandi Technologies Group
KNDI
$64.6M
| $45.3K | 0.01% |
+11,441
| New | +$38.7K |
|
1253
RLX Technology
RLX
$2.43B
| $45.1K | 0.01% |
25,460
-13,412
| -35% | -$30K |
|
|
WIMI
1254
WiMi Hologram Cloud
WIMI
$21M
| $44.8K | 0.01% |
+4,072
| New | +$41.3K |
|
1255
LiveOne
LVO
$64.1M
| $44.1K | 0.01% |
+2,505
| New | +$35.4K |
|
|
DZSI
1256
DELISTED
DZS Inc. Common Stock
DZSI
| $43.9K | 0.01% |
11,056
-9,040
| -45% | -$53K |
|
1257
Baytex Energy
BTE
$2.86B
| $43.2K | 0.01% |
13,261
-7,273
| -35% | -$25.5K |
|
1258
ADMA Biologics
ADMA
$2.02B
| $42.8K | 0.01% |
11,598
-94,398
| -89% | -$350K |
|
|
RIDE
1259
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $42.6K | 0.01% |
+20,013
| New | +$105K |
|
1260
Senseonics Holdings Inc
SENS
$255M
| $41.9K | 0.01% |
+2,746
| New | +$37.6K |
|
|
ZOM
1261
DELISTED
Zomedica Corp.
ZOM
| $41.1K | 0.01% |
+205,596
| New | +$41.7K |
|
1262
Savara
SVRA
$1.08B
| $40.5K | 0.01% |
+12,675
| New | +$29.8K |
|
|
TRVG
1263
trivago
TRVG
$385M
| $40.5K | 0.01% |
6,131
+2,994
| +95% | +$19.2K |
|
|
SVM
1264
Silvercorp Metals
SVM
$2.07B
| $40.1K | 0.01% |
14,218
-94,932
| -87% | -$323K |
|
|
KYNB
1265
Kyntra Bio
KYNB
$28.5M
| $39.8K | 0.01% |
+589
| New | +$244K |
|
|
EIGR
1266
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $39.6K | 0.01% |
1,876
-4,899
| -72% | -$151K |
|
|
HIO
1267
Western Asset High Income Opportunity Fund
HIO
$335M
| $39.4K | 0.01% |
+10,434
| New | +$39.5K |
|
1268
Pyxis Oncology
PYXS
$185M
| $39K | 0.01% |
+15,236
| New | +$48.3K |
|
1269
Arbe Robotics
ARBE
$77M
| $38.8K | 0.01% |
+13,422
| New | +$33.4K |
|
|
FRBK
1270
DELISTED
Republic First Bancorp Inc
FRBK
| $38.6K | 0.01% |
+42,906
| New | +$49.1K |
|
|
MAGN
1271
Magnera Corp
MAGN
$499M
| $38.5K | 0.01% |
981
-6,107
| -86% | -$277K |
|
1272
Rekor Systems
REKR
$86.6M
| $37.9K | 0.01% |
+21,269
| New | +$29.6K |
|
|
GAN
1273
DELISTED
GAN Ltd
GAN
| $37.8K | 0.01% |
+23,067
| New | +$32.9K |
|
1274
Genprex
GNPX
$4M
| $37.6K | 0.01% |
+1
| New | +$37.2K |
|
|
KRON
1275
DELISTED
Kronos Bio
KRON
| $37.5K | 0.01% |
+21,780
| New | +$34.6K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q2 2023 Portfolio in Review
As of Q2 2023, XTX Topco held 1,998 positions worth $558M, up 17% from $477M the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.
XTX Topco deployed $74.9M of net new capital in Q2 2023, opening 778 new positions and adding to 301 existing holdings. Its largest new stake was Target: 21,561 shares worth $2.84M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lockheed Martin, an estimated $2.31M trimmed.
- XTX Topco's largest Q2 2023 buy was Target: 21,561 shares worth $2.84M.
- XTX Topco added most to Alphabet (Google) Class A in Q2 2023, an estimated $2.42M increase.
- XTX Topco's biggest Q2 2023 reduction was Lockheed Martin, cutting an estimated $2.31M.
- XTX Topco fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $2.64M.
- XTX Topco's ten largest holdings make up 4.1% of its $558M portfolio in Q2 2023.
- XTX Topco opened 778 new positions and closed 643 in Q2 2023.
- XTX Topco's portfolio value rose 17% quarter-over-quarter to $558M.
Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.